System Transmission

Top Signal

100#1 JOB

Activity

2173Ripe

+929 today

System

Livenow

Terminal Asset View

stockNASDAQ

IMRN

$0.78-3.33%

Immuron Ltd

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

10Overripe

Live Analysis Active

Company Mission

Immuron creates oral antibody treatments that help fight infections in the gut and protect the liver. These products are used by people with traveler's diarrhea and liver conditions who need targeted therapy. The company makes money by selling its approved products and partnering with other organizations on research and development projects.

IMR

Industry Context

Immuron operates in the biotechnology sector, which focuses on developing medical treatments using biological processes. This industry is known for high research costs and long development timelines, with companies often taking years to bring products to market.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

43Matrix

Market Momentum

47.0— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.3x— Normal Volume

Today's Change

-3.33%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing IMRN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:22 PM UTC

As-of 03-15-2026 18:07 UTC

Creates oral medicines that treat gut infections and sells them through pharmacies and hospitals worldwide.

Price below key moving averages for several weeks, suggesting a sustained downtrend as sellers maintain control showing consolidation pattern.

Biotech sector showing volatility as investors rotate between risk-on and risk-off assets, creating unpredictable price swings for small-cap,.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...